ArticleJGH open : an open access journal of gastroenterology and hepatology2026
Rise in Admissions for Acute Severe Ulcerative Colitis at an Australian Health Service With a Culturally and Linguistically Diverse Population.
Article in JGH open : an open access journal of gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lowering the C-Reactive Protein (CRP) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity-Matched Analysis.Alimentary pharmacology & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Epidemiological data suggest a greater risk of inflammatory bowel disease in first- and second-generation migrants from a low to high prevalence country, with the risk of ulcerative colitis (UC) preceding Crohn's disease. This study evaluated demographic trends and outcomes of UC and acute severe ulcerative colitis (ASUC) hospitalizations in an area with an expanding multicultural population. Methods: Demographic and disease characteristics of patients admitted with UC and ASUC at a tertiary metropolitan center from January 2016 to December 2024 were recorded. Trends in presentation and 12-month outcomes in ASUC patients of European and non-European descent were compared. Results: Of 218 patient admissions with UC, 158 admissions met criteria for ASUC. A sixfold increase was seen in yearly admissions for UC (8 in 2016 to 48 in 2024) and ASUC (6 to 39, Conclusions: A significant rise in hospitalizations for UC and ASUC, with an increasing proportion of patients with UC of non-European descent. There were no significant differences in clinical outcomes in ASUC admissions in patients of non-European descent compared to European descent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.